Loss of miR-204 Drives NPTX1-Dependent Mitochondrial Dysfunction and Neuronal Degeneration in Alzheimer’s Disease
Cellular and Molecular Neurobiology · 2026
DOI: 10.1007/s10571-026-01769-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Neurobiology, 2026. Verfasst von Tae-Young Ha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Gachon University, 155 Gaetbeol-ro, Yeonsu-gu, Incheon, 21999, Korea. Hauptthemen laut MEDLINE: MicroRNAs, Alzheimer Disease, Mitochondria, Nerve Tissue Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Dementia Research Center, Korea Institute of Marine Science and Technology promotion.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is characterized by progressive cognitive decline accompanied by synaptic dysfunction and neuronal loss. Dysregulation of specific microRNAs (miRNAs) has been increasingly implicated in AD pathogenesis, suggesting that miRNA-mediated regulatory pathways may represent important mechanisms underlying neuronal vulnerability. Here, we identified mmu-microRNA-204-5p (miR-204) as a critical regulator of neuronal survival that is markedly downregulated in the hippocampus of 5xFAD mice. Through integrated bioinformatics analysis and experimental validation, we established neuronal pentraxin-1 (NPTX1) as a direct post-transcriptional target of miR-204. In primary cultured neurons, exposure to Aβ₁₋₄₂ oligomer (oAβ) drove marked upregulation of NPTX1 and precipitated neuronal injury, manifested by aberrant reactive oxygen species (ROS) accumulation, collapse of mitochondrial membrane potential, diminished cell viability, and dendritic degeneration. Inhibition of miR-204 further exacerbated these pathological changes and engaged mitochondrial apoptotic signaling, as evidenced by Bax upregulation, cytochrome c release, and caspase-3 cleavage. Conversely, restoration of miR-204 expression or genetic knockdown of NPTX1 attenuated oxidative stress, preserved mitochondrial integrity, and restored neuronal survival. Collectively, our findings uncover a previously unrecognized miR-204-NPTX1 regulatory axis that governs mitochondrial integrity and apoptotic susceptibility in AD, highlighting miR-204 as a potential therapeutic target for AD and related oxidative stress-associated neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Medicine, Gachon University, 155 Gaetbeol-ro, Yeonsu-gu, Incheon, 21999, Korea.
- Neuroscience Research Institute, Gachon University, Incheon, 21565, Korea.
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences & Technology, Gachon University, Incheon, 21999, Korea.
- Department of Pharmacology, College of Medicine, Gachon University, 155 Gaetbeol-ro, Yeonsu-gu, Incheon, 21999, Korea. keuna705@gachon.ac.kr.
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences & Technology, Gachon University, Incheon, 21999, Korea. keuna705@gachon.ac.kr.
Förderung
- Korea Dementia Research Center
- Korea Institute of Marine Science and Technology promotion
Zitieren
APA
Ha, T. Y., Lim, S. M., Park, H., & Chang, K. A. (2026). Loss of miR-204 Drives NPTX1-Dependent Mitochondrial Dysfunction and Neuronal Degeneration in Alzheimer’s Disease. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-026-01769-9
Vancouver
Ha TY, Lim SM, Park H, Chang KA. Loss of miR-204 Drives NPTX1-Dependent Mitochondrial Dysfunction and Neuronal Degeneration in Alzheimer’s Disease. Cellular and Molecular Neurobiology. 2026. doi:10.1007/s10571-026-01769-9
BibTeX
@article{Ha2026,
author = {Ha, Tae-Young and Lim, Seung Min and Park, Hyunjun and Chang, Keun-A},
title = {Loss of miR-204 Drives NPTX1-Dependent Mitochondrial Dysfunction and Neuronal Degeneration in Alzheimer’s Disease},
journal = {Cellular and Molecular Neurobiology},
year = {2026},
doi = {10.1007/s10571-026-01769-9}
}
EUVIMED